---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-018910"
form_type: "8-K"
ticker: null
cik: "0001839133"
company_name: "IR-Med, Inc."
filed_at: "2023-05-24T23:59:59+00:00"
generated_at: "2026-06-14T16:09:51.643000+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# CEO Moshe Gerber resigns; Chairperson Oded Bashan named Interim CEO

## Summary
- Moshe Gerber resigned as CEO of IR-Med, Inc. and its Israeli subsidiary, effective May 21, 2023.
- Resignation is not due to any disagreement with the company or its auditors.
- Gerber will remain available until August 19, 2023, receiving salary and benefits through August.
- Accelerated vesting of 433,333 stock options at $0.32/share, exercisable through Dec 31, 2030.
- Upon compliance, Gerber receives an additional 21,000 NIS (~$5,780) at end of notice period.

## SEC filing metadata
- accession: 0001493152-23-018910
- form_type: 8-K
- cik: 0001839133
- company_name: IR-Med, Inc.
- filed_at: 2023-05-24T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1839133/000149315223018910/0001493152-23-018910-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1839133/000149315223018910/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-018910
- JSON: https://secwatch.observer/filing/0001493152-23-018910.json
- Plain text: https://secwatch.observer/filing/0001493152-23-018910.txt

## Key facts
- Executive change
  Moshe Gerber resigned as Chief Executive Officer at IR-Med, Inc..
  - Action: resigned
  - Role: Chief Executive Officer
  source text: pursuant to which MG resigned from his role as Chief Executive Officer of the Companies.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1839133/000149315223018910/0001493152-23-018910-index.htm
- Executive change
  Oded Bashan was appointed as Interim Chief Executive Officer at IR-Med, Inc..
  - Action: appointed
  - Role: Interim Chief Executive Officer
  source text: Mr. Oded Bashan, the Chairperson and a co-founder of the Company, was appointed as Interim Chief Executive Officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1839133/000149315223018910/0001493152-23-018910-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.